These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32242103)

  • 1. CUGC for hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome.
    Martinelli D; Fiermonte G; Häberle J; Boenzi S; Goffredo BM; Travaglini L; Agolini E; Porcelli V; Dionisi-Vici C
    Eur J Hum Genet; 2020 Jul; 28(7):982-987. PubMed ID: 32242103
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis and high incidence of hyperornithinemia-hyperammonemia-homocitrullinemia (HHH) syndrome in northern Saskatchewan.
    Sokoro AA; Lepage J; Antonishyn N; McDonald R; Rockman-Greenberg C; Irvine J; Lehotay DC
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S275-81. PubMed ID: 20574716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.
    Martinelli D; Diodato D; Ponzi E; Monné M; Boenzi S; Bertini E; Fiermonte G; Dionisi-Vici C
    Orphanet J Rare Dis; 2015 Mar; 10():29. PubMed ID: 25874378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome in adulthood: a rare recognizable condition.
    Filosto M; Alberici A; Tessa A; Padovani A; Santorelli FM
    Neurol Sci; 2013 Sep; 34(9):1699-701. PubMed ID: 23247599
    [No Abstract]   [Full Text] [Related]  

  • 5. Insights into the mutation-induced HHH syndrome from modeling human mitochondrial ornithine transporter-1.
    Wang JF; Chou KC
    PLoS One; 2012; 7(1):e31048. PubMed ID: 22292090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Milder Form of Urea Cycle Defect Revisited: Report and Review of Hyperornithinaemia-Hyperammonaemia-Homocitrullinuria (HHH) Syndrome Diagnosed in a Teenage Girl Presenting with Recurrent Encephalopathy.
    Qadri SK; Ting TW; Lim JS; Jamuar SS
    Ann Acad Med Singap; 2016 Dec; 45(12):563-566. PubMed ID: 28062886
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperornithinemia-hyperammonemia-homocitrullinuria: a rare neurometabolic disorder in two siblings.
    Rizkallah D; Daher RT; Haddad L; Karam PE
    Metab Brain Dis; 2024 Jun; 39(5):909-913. PubMed ID: 38833093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible Leukoencephalopathy in a Man with Childhood-onset Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome.
    Hoshino Y; Kodaira M; Matsuno A; Kaneko T; Fukuyama T; Takano K; Yazaki M; Sekijima Y
    Intern Med; 2022 Feb; 61(4):553-557. PubMed ID: 34433721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical diagnosis and treatment of three cases with hyperornithinemia-hyperammonemia-homocitrullinuria syndrome].
    Guan HZ; Ding Y; Li DX; Dong H; Song JQ; Jin Y; Zhu ZJ; Sun LY; Yang YL
    Zhonghua Er Ke Za Zhi; 2017 Jun; 55(6):428-433. PubMed ID: 28592010
    [No Abstract]   [Full Text] [Related]  

  • 10. Corticospinal tract damage in HHH syndrome: a metabolic cause of hereditary spastic paraplegia.
    Olivieri G; Pro S; Diodato D; Di Capua M; Longo D; Martinelli D; Bertini E; Dionisi-Vici C
    Orphanet J Rare Dis; 2019 Aug; 14(1):208. PubMed ID: 31443672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune Alterations in a Patient With Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome: A Case Report.
    Silvera-Ruiz SM; Gemperle C; Peano N; Olivero V; Becerra A; Häberle J; Gruppi A; Larovere LE; Motrich RD
    Front Immunol; 2022; 13():861516. PubMed ID: 35711415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of four patients affected by HHH syndrome.
    Kim SZ; Song WJ; Nyhan WL; Ficicioglu C; Mandell R; Shih VE
    Clin Chim Acta; 2012 Jul; 413(13-14):1151-5. PubMed ID: 22465082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactate/pyruvate in hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.
    Ono H; Tamada T; Shigematsu Y
    Pediatr Int; 2018 Aug; 60(8):762-764. PubMed ID: 30058227
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathogenic potential of SLC25A15 mutations assessed by transport assays and complementation of Saccharomyces cerevisiae ORT1 null mutant.
    Marobbio CM; Punzi G; Pierri CL; Palmieri L; Calvello R; Panaro MA; Palmieri F
    Mol Genet Metab; 2015 May; 115(1):27-32. PubMed ID: 25818551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late onset hyperornithinemia-hyperammonemia-homocitrullinuria syndrome - how web searching by the family solved unexplained unconsciousness: a case report.
    Silfverberg T; Sahlander F; Enlund M; Oscarson M; Hårdstedt M
    J Med Case Rep; 2018 Sep; 12(1):274. PubMed ID: 30243302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel mutations in the SLC25A15 gene in hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome: a clinical, molecular, and functional study.
    Tessa A; Fiermonte G; Dionisi-Vici C; Paradies E; Baumgartner MR; Chien YH; Loguercio C; de Baulny HO; Nassogne MC; Schiff M; Deodato F; Parenti G; Rutledge SL; Vilaseca MA; Melone MA; Scarano G; Aldamiz-Echevarría L; Besley G; Walter J; Martinez-Hernandez E; Hernandez JM; Pierri CL; Palmieri F; Santorelli FM
    Hum Mutat; 2009 May; 30(5):741-8. PubMed ID: 19242930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disturbance of redox homeostasis by ornithine and homocitrulline in rat cerebellum: a possible mechanism of cerebellar dysfunction in HHH syndrome.
    Zanatta A; Viegas CM; Tonin AM; Busanello EN; Grings M; Moura AP; Leipnitz G; Wajner M
    Life Sci; 2013 Aug; 93(4):161-8. PubMed ID: 23806752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular manifestations in hyperornithinemia-hyperammonemia-homocitrullinuria syndrome: a rare association.
    Kumar K; Agarwal A; Agarwal A; Dhawan A; Chandani N; Raj P
    Retin Cases Brief Rep; 2015; 9(2):134-7. PubMed ID: 25411929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mutation in the SLC25A15 gene in a Turkish patient with HHH syndrome: functional analysis of the mutant protein.
    Ersoy Tunalı N; Marobbio CM; Tiryakioğlu NO; Punzi G; Saygılı SK; Onal H; Palmieri F
    Mol Genet Metab; 2014 May; 112(1):25-9. PubMed ID: 24721342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ornithine In Vivo Administration Disrupts Redox Homeostasis and Decreases Synaptic Na(+), K (+)-ATPase Activity in Cerebellum of Adolescent Rats: Implications for the Pathogenesis of Hyperornithinemia-Hyperammonemia-Homocitrullinuria (HHH) Syndrome.
    Zanatta Â; Viegas CM; Hickmann FH; de Oliveira Monteiro W; Sitta A; de Moura Coelho D; Vargas CR; Leipnitz G; Wajner M
    Cell Mol Neurobiol; 2015 Aug; 35(6):797-806. PubMed ID: 25772141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.